Education
About Us
Working with TipRanks
Follow Us
Electromed (ELMD)
:ELMD
ELMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.74 - $35.56
Previous CloseN/A
Volume34.94K
Average Volume (3M)111.98K
Market Cap
$209.21M
Enterprise Value$248.34M
Total Cash (Recent Filing)$16.23M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)32.4
Beta0.52
Next Earnings
May 13, 2025EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.76
Shares Outstanding8,556,844
10 Day Avg. Volume69,413
30 Day Avg. Volume111,982
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)N/A
Price to Sales (P/S)3.55
Price to Cash Flow (P/CF)16.80
P/FCF Ratio16.20
Enterprise Value/Market Cap1.19
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.95
Enterprise Value/Ebitda27.37
Forecast
1Y Price Target
$37.00Price Target Upside53.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Electromed News
PremiumCompany Announcements
Electromed Announces $5 Million Share Buyback Program
PremiumCompany Announcements
Electromed Soars with Record Revenues and Growth
PremiumCompany Announcements
Electromed Reports Record Growth in Q2 2025PremiumCompany Announcements
Electromed Reports Record Q2 2025 Financial Performance---
Bulls Say, Bears Say
Bulls Say
Financial HealthThe company has $16M in cash, $23M in accounts receivable, no debt, and is the final remaining pure-play in the HFCWO space, making it an attractive takeout target for a larger medtech strategy.
Management And OperationsThe new management team and board have accomplished growth through product enhancements, sales force productivity, leaner and more efficient reimbursement, market development efforts, and streamlined operations.
Bears Say
Market PenetrationAs the Company continues to gain traction in the underpenetrated bronchiectasis market, multiple expansion is warranted.
---
Options Prices
Currently, No data available
---
Ownership Overview
8.62% Insiders
8.88% Mutual Funds
12.80% Other Institutional Investors
64.10% Public Companies and
Individual Investors
ELMD FAQ
What was Electromed’s price range in the past 12 months?
Electromed lowest stock price was $13.74 and its highest was $35.56 in the past 12 months.
What is Electromed’s market cap?
Electromed’s market cap is $209.21M.
When is Electromed’s upcoming earnings report date?
Electromed’s upcoming earnings report date is May 13, 2025 which is in 48 days.
How were Electromed’s earnings last quarter?
Electromed released its earnings results on Feb 11, 2025. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.04.
Is Electromed overvalued?
According to Wall Street analysts Electromed’s price is currently Undervalued.
Does Electromed pay dividends?
Electromed does not currently pay dividends.
What is Electromed’s EPS estimate?
Electromed’s EPS estimate is 0.2.
How many shares outstanding does Electromed have?
Electromed has 8,556,844 shares outstanding.
What happened to Electromed’s price movement after its last earnings report?
Electromed reported an EPS of $0.22 in its last earnings report, beating expectations of $0.18. Following the earnings report the stock price went up 13.973%.
Which hedge fund is a major shareholder of Electromed?
Currently, no hedge funds are holding shares in ELMD
---
Electromed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.00 (53.46% Upside)
$37.00 (53.46% Upside)
Blogger Sentiment
Bullish
ELMD Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.8%
Last 30 Days ▼ 13.9%
Last 30 Days ▼ 13.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.90%
12-Months-Change
Fundamentals
Return on Equity
16.11%
Trailing 12-Months
Asset Growth
11.31%
Trailing 12-Months
Company Description
Electromed
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
---
ELMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with record revenues, growth in multiple segments, and efficient financial management. While there were some increases in expenses and minor fluctuations in revenue, the overall outlook remains positive with continued growth and strategic investments.Read More>---
ELMD Stock 12 Month Forecast
Average Price Target
$37.00
▲(53.46% Upside)
Technical Analysis
ICU Medical
―
Luna Innovations
―
Tandem Diabetes Care
―
BioLife Solutions
―
Senseonics Holdings
―
Best Analysts Covering ELMD
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
+4.52%
initiated a buy rating last month
Copying Kyle Bauser's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +4.52% per trade.
---